Xenobiotics that affect oxidative phosphorylation alter differentiation of human adipose-derived stem cells at concentrations that are found in human blood by Llobet, Laura et al.
RESEARCH ARTICLE
Xenobiotics that affect oxidative phosphorylation alter
differentiation of human adipose-derived stem cells at
concentrations that are found in human blood
Laura Llobet1,2,3, Janne M. Toivonen1,2, Julio Montoya1,2,3, Eduardo Ruiz-Pesini1,2,3,4,*,‡ and
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ABSTRACT
Adipogenesis is accompanied by differentiation of adipose tissue-
derived stem cells to adipocytes. As part of this differentiation,
biogenesis of the oxidative phosphorylation system occurs. Many
chemical compounds used in medicine, agriculture or other human
activities affect oxidative phosphorylation function. Therefore, these
xenobiotics could alter adipogenesis. We have analyzed the effects
on adipocyte differentiation of some xenobiotics that act on the
oxidative phosphorylation system. The tested concentrations have
been previously reported in human blood. Our results show that
pharmaceutical drugs that decrease mitochondrial DNA replication,
such as nucleoside reverse transcriptase inhibitors, or inhibitors of
mitochondrial protein synthesis, such as ribosomal antibiotics, diminish
adipocyte differentiation and leptin secretion. By contrast, the
environmental chemical pollutant tributyltin chloride, which inhibits
the ATP synthase of the oxidative phosphorylation system, can
promote adipocyte differentiation and leptin secretion, leading to
obesity and metabolic syndrome as postulated by the obesogen
hypothesis.
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INTRODUCTION
The white adipose tissue (WAT) stores energy as triglycerides and
secretes endocrine factors such as adipokines. Most WAT mass or
volume consists of mature adipocytes. In adult humans, the number
of these cells is remarkably stable because new adipocytes
differentiate constantly to replace lost adipocytes (Spalding et al.,
2008).
In vitro differentiation of 3T3-L1 mouse preadipocytes, one of
the best characterized models for studying adipogenesis (Green and
Kehinde, 1975; Kita et al., 2009), is accompanied by a remarkable
increase in the expression of numerous mitochondrial proteins
(Newton et al., 2011). The increased basal rate of oxygen
consumption in adipocytes compared with preadipocytes could be
a clear manifestation of augmented biogenesis of the oxidative
phosphorylation (OXPHOS) system during the adipogenic process
(Wilson-Fritch et al., 2003). The levels of assembled OXPHOS
complexes and mitochondrial DNA (mtDNA) copy number also
increase with the adipocyte differentiation of 3T3-L1 cells (Ryu
et al., 2013; Shi et al., 2008).
Genetic manipulation of the OXPHOS system can affect
adipocyte differentiation. Mouse preadipocytes that overexpress
mesodermal developmental transcription factor Tbx15 have
reduced mitochondrial mass, basal respiration and mtDNA gene
expression. These cells show an impaired differentiation to
adipocytes and reduced triglyceride accumulation (Gesta et al.,
2011). Mouse adipose tissue-derived stem cells (mASCs) that
lacked the CR6/gadd45-interacting protein Gadd45gip1/Crif1, a
translation/assembly factor for mtDNA-derived polypeptides,
express lower levels of mtDNA-encoded OXPHOS subunits and
display disrupted adipocyte differentiation (Ryu et al., 2013). The
expression of mitochondrial transcription factor A (TFAM), a key
factor for mtDNA transcription and replication, is increased with
adipogenic differentiation of human mesenchymal stem cells
(hMSCs). When TFAM expression is suppressed in hMSCs with
small interfering RNA, expression of the gene encoding NADH-
ubiquinone oxidoreductase chain 2 (MT-ND2) is lowered and
adipogenic differentiation, as determined by adiponectin mRNA
levels, is inhibited (Zhang et al., 2013).
In addition to genetic intervention, physiologic or pharmacologic
manipulation of OXPHOS can also affect adipogenic
differentiation. Oxygen is the ultimate electron acceptor in the
OXPHOS electron transport chain (ETC) and hypoxia (1% O2)
restrains adipogenic differentiation in both mouse preadipocytes
and hMSCs (Carriere et al., 2004; Zhang et al., 2013). Nucleoside
reverse transcriptase inhibitors (NRTIs) used in human
immunodeficiency virus (HIV) treatment inhibit mtDNA
polymerase-γ, the enzyme required for mtDNA replication. This
provokes mtDNA depletion and decreases adipogenesis in mouse
and human preadipocytes (Caron et al., 2004; Stankov et al., 2010,
2013, 2008; Walker et al., 2006).
Numerous chemical compounds used in medicine, agriculture or
other human activities can affect OXPHOS function (Degli Esposti,
1998; Nadanaciva and Will, 2011; Wallace, 2008). Because
OXPHOS appears to be important for adipocyte differentiation,
xenobiotics could also alter adipogenesis. However, xenobiotics are
very frequently tested at high concentrations that would never be
found in humans. Therefore, we have investigated the effects on
adipogenic differentiation of some OXPHOS xenobiotics at low
concentrations. Our results support the view that OXPHOS
xenobiotics might interfere with mitochondrial ETC and alter
adipogenic differentiation in concentrations already reported
present in human circulation.Received 1 June 2015; Accepted 3 September 2015
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RESULTS
Characterization of humanadipose tissue-derived stemcells
Prior to exposing the cells under study to xenobiotics, they were
confirmed to display characteristics typical of human adipose
tissue-derived stem cells (hASCs). As previously described (Gir
et al., 2012), hASCs were found to adhere to plastic, express
mRNAs for the hASC marker proteins cluster of differentiation 90
(CD90/THY1) and 105 (CD105/ENG) (Fig. 1A) and possess the
capacity to undergo adipogenic, osteogenic and chondrogenic
differentiation (Fig. 1B-E). To genetically characterize these cells,
the nuclear genetic fingerprint of 16 short tandem repeats and the
whole mtDNA sequence were obtained (Fig. 2A,B). Two different
lots of hASCs were used (hASCs-1 and hAScs-2), originating from
different donors. The mtDNA haplogroup of hASCs-1 was
T2c1d1a and that of hASCs-2 was H10e2. In the organelle
genomes, there were no private mutations and none of the genetic
variants was apparently pathologic (GenBank KR816716,
KR816717) (van Oven and Kayser, 2009). Because all the
experiments described here were completed before passage 10,
karyotype analysis of the hASCs was performed in this passage.
All 20 metaphase preparations were found to be normal 46,XX
(Fig. 2C).
It has been previously shown that the glucose concentration in
the culture medium can affect different mitochondrial parameters
(Weber et al., 2002). We observed that very glycolytic tumor cell
lines, such as osteosarcoma 143B cybrids, consumed all medium
glucose when grown at low (5 mM) glucose concentration for 48 h
(Fig. S1A). Compared with cells grown without glucose, they
showed significantly lower quantities of respiratory complex IV
(CIV) (Fig. S1B). At high (25 mM) glucose concentration, the
sugar concentration in the medium was greatly decreased after
48 h. CIV specific activity and quantity were significantly lower at
high glucose than those from cells growing without glucose. The
CIV quantity and specific activity of citrate synthase (CS), a
volumetric marker of cell fraction occupied by mitochondria, were
also significantly lower at high glucose than in cells growing at
low glucose. In contrast, glucose consumption by hASCs was
almost negligible over 72 h (Fig. 1F). It is possible that hASCs
preferably use other substrates, such as pyruvate or glutamine, as
energy source (Reitzer et al., 1979). As found in other studies
(Keuper et al., 2014), mitochondrial parameters such as CS
specific activity, CIV specific activity or quantity (Fig. 1G) and
oxygen consumption (Fig. 1H) were not affected by glucose in
hASCs.
Several reports have proposed the use of hypoxia for
maintaining undifferentiated stem cell cultures, but it is known
that hypoxia can also stimulate differentiation (Abdollahi et al.,
2011). At 3% oxygen, the mRNA levels of hypoxia markers
phosphofructokinase L (PFKL) and vascular endothelium-derived
growth factor (VEGF) significantly increased (Fig. 1I) (Lee
et al., 2009), as did the number of mtDNA copies and CS
specific activity (Fig. 1J), suggesting mitochondrial biogenesis.
However, even though CIV quantity tended to increase, CIV
specific activity significantly decreased in hypoxia. The hASC
doubling time in hypoxia was 45.8 h as opposed to 26.3 h in
normoxia (Fig. 1K). Furthermore, the shift to hypoxic conditions
slowed adipogenic differentiation but, surprisingly, chondrogenic
and osteogenic differentiation was favored by induction of
adipogenic differentiation (Fig. 1L-N) (Choi et al., 2014; Wang
et al., 2005).
As a result of the slower hASC proliferation rate, the difficulty
to induce adipocyte differentiation and confounding effects of
chondro/osteogenesis of hASCs under hypoxia, all differentiation
experiments were performed at 20% oxygen. Because of the
reported delay in adipogenic lineage commitment of hMSCs after
glucose reduction (Lo et al., 2011), we also performed these
experiments at 25 mM glucose, in spite of the fact that these
conditions do not faithfully replicate the true physiological
conditions under which hASCs undergo differentiation in vivo.
Cell morphology and metabolic alterations during
adipogenic differentiation
As expected, adipogenic differentiation medium slowed hASC
proliferation. ThemRNA levels of hASCmarker proteins CD90 and
TRANSLATIONAL IMPACT
Clinical issue
Adipogenesis, the process by which adipocytes are generated from
precursor cells, requires high levels of cellular energy. In line with this, an
increase in biogenesis of the oxidative phosphorylation system
(OXPHOS) is observed in differentiating preadipocytes. Genetic
manipulation of OXPHOS is known to negatively affect adipocyte
differentiation in model systems, and defects in OXPHOS are
associated with a wide range of human multisystem disorders,
reflecting its importance in cellular metabolism. Unfortunately, this
system is often an unintended target of drug therapies and is
responsible, at least in part, for the dose-limiting side effects
associated with a large array of pharmaceuticals. Moreover, OXPHOS
is frequently the target of many environmental toxins (xenobiotics). In
general, the effects of xenobiotics on OXPHOS have been assessed by
applying high concentrations that would not be found in humans. Here,
the authors evaluate the effects on cell differentiation and function of
OXPHOS-targeting xenobiotics at concentrations that have been
reported in human circulation.
Results
Isolated human adipose tissue-derived stem cells (hASCs) were used to
model adipocyte differentiation. As proof-of-principle, the authors first
showed that OXPHOS biogenesis is enhanced during the differentiation
of these cells. They then evaluated the effect of different xenobiotics,
using concentrations that are usually found in human blood. Because
some essential polypeptides for OXPHOS biogenesis are mitochondrial
DNA (mtDNA)-encoded, the team tested compounds that could interfere
with mtDNA replication or translation. Inhibitors of mtDNA replication,
including nucleoside reverse transcriptase inhibitors used in the
antiretroviral therapy of individuals with AIDS, and inhibitors of mtDNA
translation, including ribosomal antibiotics used to fight bacterial
infections, were found to decrease cell triglycerides and leptin
secretion. On the other hand, an inhibitor of the OXPHOS ATP
synthase, the environmental chemical pollutant tributyltin chloride,
increased triglyceride levels and leptin discharge.
Implications and future directions
This work supports previous studies that indicate that OXPHOS
biogenesis is important for adipocyte differentiation. Clinical drugs that
reduce mtDNA gene expression, such as inhibitors of mtDNA replication
or translation, decrease OXPHOS biogenesis and alter adipogenesis,
even at low concentrations. Exposure to environmental toxins that modify
OXPHOS complex activities can also interfere with adipocyte
differentiation. This finding lends weight to the obesogen hypothesis,
in which it is proposed that environmental contaminants have contributed
to the increase in obesity and relatedmetabolic disorders in recent years.
Important OXPHOS components are mtDNA-encoded. These
polypeptides, by themselves or after their interaction with different
xenobiotics, modify OXPHOS capacity. Thus, mtDNA genetic variability
might also affect adipocyte differentiation and related phenotypes, with
potentially pathological consequences.
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Fig. 1. hASC characterization. (A) Expression of hASC marker mRNAs. White bars represent hASCs. Striped bars represent neuroblastoma SK-N-BE(2)-C
cells, as a negative control. *P≤0.0044. (B-E) Representative microscopy images of hASCs (B), hASCs differentiated to adipocytes (Oil Red) (C), hASCs
differentiated to osteocytes (D) and hASCs differentiated to chondrocytes (micromass culture) (E). (F) Glucose concentration of hASC culture medium. Black and
white circles indicate 25 and 5 mM glucose, respectively. (G) Mitochondrial enzymes specific activities (s.a.) and levels (q). White bars indicate the value of
enzymatic parameters of cells grown at 5 mM glucose. Dotted line represents the value of these variables for cells grown at 25 mM glucose. (H) Oxygen
consumption of cells grown at 25 mM (black bars) and 5 mM (white bars) glucose. (I) Expression of hypoxia (3% O2) mRNA markers. Dotted line at 100%
represents the value of these variables at 20% oxygen. *P≤0.0162. (J) Effect of hypoxia on mitochondrial variables. Dotted line represents the value of these
variables at 20% oxygen. *P≤0.0178. (K) hASC doubling time. Black or white circles indicate normoxia or hypoxia, respectively. (L-N) Representative optical
microscopy images of hASCs differentiated to adipocytes (Nile Red) (L), chondrocytes (normal culture) (M) and osteocytes (N) in hypoxia.
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CD105 decreased by 57.4% and 40.8%, respectively (Fig. 3A). The
onset of differentiation was not completely synchronized and, as
previously reported (Hofmann et al., 2012; Keuper et al., 2014), a
certain percentage of the cells (approximately 50% in our case) did
not differentiate at all. Compared with undifferentiated hASCs
(Fig. 3B,C), differentiated cells showed a morphological change
and increased volume (Fig. 3D,E) which, at times, has been reported
to be as high as 20-fold (von Heimburg et al., 2005). The increased
size was only partially associated with higher protein content
(Fig. 3F) and mainly represented accumulation of lipid droplets, as
shown by lipophilic staining (Fig. 3G,H) and triglyceride assay
(Fig. 3I). The appearance of lipid droplets is a clear indicator of
adipocyte differentiation.
As described in other reports (Gesta et al., 2011; Hofmann et al.,
2012; Keuper et al., 2014; Vankoningsloo et al., 2006; Zhang et al.,
2013), the induction of adipogenic differentiation led to expression
of mRNAs for adipocyte markers adiponectin, leptin, fatty acid
binding protein 4 (FABP4), peroxisome proliferator-activated
Fig. 2. hASC genetic characterization.
(A) Nuclear genetic fingerprints. (B) mtDNA
genetic variants. Sequences are compared
with the revised Cambridge reference
sequence (rCRS). (C) Karyotypes.
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receptor gamma coactivator 1-alpha (PGC1α) and peroxisome
proliferator-activated receptor gamma (PPARγ) which, except for
PPARγ, were not expressed at quantifiable levels in undifferentiated
hASCs (Fig. 3J). Consistently, protein levels for intracellular
FABP4 (Fig. 3K) and secreted FABP4, adiponectin and leptin
(Fig. 3L) were greatly induced (Dicker et al., 2005).
Mitochondrial morphology and the OXPHOS system during
adipogenic differentiation
Small, round mitochondria with few cristae are commonly found
in small numbers, often in the perinuclear cytoplasm of
undifferentiated hASCs (Fig. 4A,B). In adipocytes (Fig. 4C,D),
numerous, large and extended mitochondria with multiple cristae
Fig. 3. Adipogenic differentiation. (A) Expression of hASC marker mRNAs. White and gray bars represent hASCs and adipocytes, respectively. *P=0.0035.
(B,C) Representative optical (B) and electron microscopy (C) images of hASCs. (D,E) Representative optical (D) and electron microscopy (D) images of
adipocytes. (F) Cell protein amount. White and gray bars represent the protein quantity per million cells of hASCs and adipocytes, respectively. *P=0.0314.
(G,H) Representative microscopy images of adipocytes stained with Nile Red (G) or Oil Red O (H). (I) Cell triglyceride levels. White and gray bars represent the
quantity of triglycerides in hASCs and adipocytes, respectively. *P<0.0001. (J) Expression of PPARγ mRNA. White and gray bars represent hASCs and
adipocytes, respectively. *P=0.0442. (K) Representative immunocytochemical image of adipocytes FABP4. (L) Adipokine levels secreted by adipocytes. Dotted
line represents the levels found in the hASC culture medium. *P≤0.0117.
1445
RESEARCH ARTICLE Disease Models & Mechanisms (2015) 8, 1441-1455 doi:10.1242/dmm.021774
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
Fig. 4. Mitochondrial changes during adipocyte differentiation. (A,B) Representative electronmicroscopy images of part of a hASC (A) andmitochondria (B).
(C,D) Representative electronmicroscopy images of an adipocyte fragment (C) andmitochondrion (D). (E) Representativemicroscopy image of themitochondrial
disposition in adipocytes. (F) MIMS. White and gray bars represent hASC and adipocyte MIMS values, respectively. (G) MIMP. White and gray bars represent
hASC and adipocyte MIMP values, respectively. *P=0.0034. Inserts: representative images of hASCs (left) and adipocytes (right) stained with a dye used to
measureMIMP. Green changes to orangewhenMIMP increases. (H) Oxygen consumption. White and gray bars represent values of consumed oxygen in hASCs
and adipocytes, respectively. *P≤0.0361. (I) Mitochondrial enzyme specific activities and quantity (q) in adipocytes. Dotted line represents enzyme activities and
amount found in hASCs. *P≤0.0388. (J) Mitochondrial protein synthesis. Representative gel showing the electrophoretic patterns of mitochondrial translation
products (ND1-6,CYB, CO1-3 and ATP6,8) (right) and loading controls (left). M, molecular weight marker; U, undifferentiated cells (hASCs); D, differentiated cells
(adipocytes). Insert: quantification of mitochondrial translation products (MTPs) in adipocytes. Dotted line represents the level of MTPs in hASCs. *P=0.0210.
(K) Mitochondrial transcripts in adipocytes. Mitochondrial RNA levels (12S, CO1 and ND6) represent the three transcription units of the mtDNA. Dotted line
represents levels in hASCs. *P≤0.0104. (L) mtDNA levels. White and gray bars represent the mtDNA amount in hASCs and adipocytes, respectively. (M) H2O2
quantity and SOD2 mRNA levels in adipocytes. Dotted line represents levels of these parameters in hASCs. *P≤0.0463.
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are preferentially distributed between the cytoplasmic lipid
droplets. These results were confirmed in live cells using a
mitochondrial stain (Fig. 4E). Although simple microscopic
observation suggested that the mitochondrial inner membrane
surface (MIMS) would be larger in differentiated cells, the
increase was not found to be significant according to cardiolipin
assay (Fig. 4F). This can probably be explained by the fact that
only approximately half of the cells used for quantitative assay
were differentiated.
The mitochondrial inner membrane potential (MIMP), which
drives OXPHOS, was significantly augmented with differentiation
(Fig. 4G). The endogenous, leak state and uncoupled oxygen
consumption per cell significantly increased with differentiation
(Fig. 4H). However, these parameters did not change when
normalized by protein amount or CS specific activity.
Accordingly, specific activities of CS and CIV, and the quantity
of CIV per cell, also increased with differentiation. The increase in
respiratory complex II (CII) specific activity was also suggestive
(Fig. 4I). Again, these parameters did not change when normalized
by CS specific activity. All these biochemical results confirm
mitochondrial biogenesis during differentiation. Despite the
increase in mitochondrial biogenesis, mitochondrial protein
synthesis in differentiated cells was lower than in undifferentiated
cells (Fig. 4J). Actively dividing, undifferentiated cells are likely to
require continuous mitochondrial protein synthesis to produce
mitochondria for the new cells. However, differentiated, non-
proliferating cells only need to replace the degraded mitochondrial
proteins of existent cells. In agreement with protein levels, the RNA
expression for three mtDNA-encoded products (representing three
mtDNA transcription units) also decreased with adipocyte
differentiation (Fig. 4K), although mtDNA levels remained
unaltered (Fig. 4L).
Despite the observed increase in MIMP, the hydrogen peroxide
(H2O2) levels were significantly reduced in differentiated cells
(Fig. 4M). This is probably a consequence of increased expression
of antioxidant enzymes during adipogenic differentiation (Higuchi
et al., 2013). Indeed, it was demonstrated that adipogenesis was
accompanied by significantly increased levels of mRNA for
manganese superoxide dismutase (SOD2) (Fig. 4M).
OXPHOS xenobiotics and adipogenic differentiation
Nucleoside reverse transcriptase inhibitors: Zidovudine and
Zalcitabine
As previously commented, NRTIs, in addition to their antiretroviral
effects, inhibitmtDNApolymerase-γ, altermitochondrial function and
can result in disturbed cellular differentiation. Two NRTIs, 3′-azido-
3′-deoxythymidine (Zidovudine, AZT) and 2′,3′-dideoxycytidine
(Zalcitabine, ddC) were tested here at concentrations close to their
maximum reported concentration in human plasma (Gustavson et al.,
1990; Laskin et al., 1989).
Whereas AZT at 6 μM had no effect on intracellular or secreted
markers of adipogenesis, ddC at 0.1 μM significantly decreased
Nile Red staining, triglycerides and secreted leptin (Fig. 5A).
Adipogenic differentiation of hASCs decreased H2O2 levels
(Fig. 4M) and, consistent with its effects on adipogenesis, ddC
(but not AZT) was associated with increased H2O2 levels (Fig. 5B).
Neither AZT nor ddC had any effect on CS specific activity,
suggesting lack of a general effect on mitochondrial biogenesis
(Fig. 5C). However, as expected from inhibitors of mtDNA
polymerase, mtDNA levels were significantly reduced.
Additionally, AZT (but not ddC) increased CIV quantity and
specific activity, normalized by CS specific activity.
ddC treatment during adipogenic differentiation provoked
reduction of some adipocyte markers but had no effect on
mitochondrial enzymes. However, when hASCs were treated with
0.1 μM ddC for 10 days and then differentiated in the absence of
drug, they did not show any difference from untreated cells with
regards to adipocyte markers (Fig. 5D), but CS specific activity was
significantly decreased and CIV specific activity and quantity,
normalized by CS specific activity, were significantly increased
(Fig. 5E).
Ribosomal antibiotics: chloramphenicol and linezolid
Because of the bacterial origin of mitochondria, some ribosomal
antibiotics also inhibit mitochondrial protein synthesis. Two
inhibitors of bacterial protein synthesis, chloramphenicol (CAM)
and linezolid (LIN), bind the large subunit of the mitochondrial
ribosome and produce myelosuppression, lactic acidosis and optical
and peripheral neuropathy (Pacheu-Grau et al., 2010). Both CAM at
2.5 μM, a concentration below the lower limit of its therapeutic
range (Balbi, 2004), and LIN at 30 μM, a concentration below
the steady-state peak serum concentrations (Dryden, 2011),
significantly decreased the amount of triglycerides and secreted
leptin (Fig. 6A). However, Nile Red staining and adiponectin and
FABP4 levels were not significantly affected. CAM, but not LIN at
30 or 60 μM, increased production of reactive oxygen species
(ROS) (Fig. 6B). CAM, but not LIN, decreased CS specific activity
(Fig. 6C). Interestingly, the ratio CIV (specific activity or quantity)/
CS specific activity seemed to be altered in opposite directions by
the two antibiotics, whereas mtDNA levels remained unaltered.
Consistent with a negative effect of LIN on CIV quantity, a general
decrease in mitochondrial protein synthesis was observed in the
presence of the drug (Fig. 6D).
To rule out a particular effect of LIN on the specific hASCs used
(hASCs-1), we analyzed in parallel the influence of 30 or 60 μM
LIN on other hASCs (hASCs-2) derived from a different donor
(Fig. 2). LIN at 30 μM provoked similar effects on hASCs-2 as
observed on hASCs-1, except for CS specific activity, which was
significantly increased (Fig. 6E). At 60 μM LIN, the effects on
both lots of hASCs were more pronounced: the CIV/CS ratios and
the levels of secreted leptin were significantly lower than at 30 μM
in both cell lines (Fig. 6E). Interestingly, at 60 μM, the CIV/CS
specific activities ratio and the secreted leptin were also
significantly lower in hASCs-2 than in hASCs-1 (Fig. 6E). This
suggests that genetic polymorphisms modify the susceptibility of
hASCs to antibiotics targeting mitochondrial ribosomes.
Environmental toxins: tributyltin chloride
The organotin tributyltin chloride (TBTC) is a potent algicide and
molluscicide. Widespread environmental contamination of marine
ecosystems with tributyltins (TBT) began in the 1960s when it
became ubiquitous as the active component in marine antifouling
paints for ships. However, environmental contamination by TBT
goes beyond aquatic ecosystems; they are also frequently used in
many industrial and agricultural activities. All this has led to
concern over their effects on human health. As a result, a global ban
on the use of organotin-based antifouling paints was enacted from
2003 onward (Grun, 2014).
It was previously shown that TBT induces lipid droplet
accumulation in human keratinocytes and adipogenic differentiation of
mouse preadipocyte cells (Corsini et al., 2003;Kanayama et al., 2005).
Bovine submitochondrial particles treated with TBT were found to
synthesize ATP at very low rates, and it was reported that subunit
p.MT-ATP6 of the OXPHOS complex V (CV, or ATP synthase) was
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the target site for inhibition by TBT (Matsuno-Yagi and Hatefi, 1993;
von Ballmoos et al., 2004). However, these data were obtained at
relatively high concentrations of the drug (Kotake, 2012). TBT
concentrations in human blood have been found to range from 16.8 to
306.8 nM (Kannan et al., 1999; Whalen et al., 1999), and TBT at
10 nM can activate genomic pathways via PPARγ and retinoid X
receptor alpha (RXRα) (Kanayama et al., 2005). It has also been
shown recently that, depending on the exposure window, TBT can
promote adipogenesis independently of PPARγ (Biemann et al.,
2014). Inhibition of isocitrate dehydrogenase (IDH) at nanomolar
levels has been demonstrated as a non-genomic, endocrine-disrupting
mechanism (Yamada et al., 2014).
In the preliminary test for the effects of TBTC on hASCs it was
recorded that another CV inhibitor, oligomycin (OLI) at 16 nM,
induced similar morphological changes in cells as those observed
with TBTC (Fig. 7A-D). TBTC at 20 and 100 nM significantly
increased the intracellular (Nile Red, triglycerides) and secreted
(leptin) markers of adipogenesis in hASCs grown for 21 days in
normal, non-differentiation media (Fig. 7E and Fig. S2). Similar
results were obtained for OLI at 16 nM. However, in our hands,
neither TBTC nor OLI decreased IDH activity. On the contrary,
TBTC at 100 nM or OLI at 16 nM significantly increased IDH
activity (Fig. 7F), probably mirroring a compensatory response for
increasing mitochondrial biogenesis. As expected from direct
inhibitors of ATP synthase, both OLI and TBTC (at 100 nM)
decreased oxygen consumption of hASCs (Fig. 7G) and the effect
of TBTC was shown to be immediate (Fig. 7H). TBTC at 100 nM
did not affect the levels of H2O2 but, unexpectedly, OLI was found
to immediately decrease these levels (Fig. 7I). The assay was
confirmed functional by addition of antioxidant N-acetyl-cysteine
Fig. 5. Response of adipogenic and mitochondrial parameters to NRTIs. Dark and light blue bars indicate treatment with 6 μM AZT and 0.1 μM ddC,
respectively. Dotted lines represent levels in untreated adipocytes. (A) Adipogenic variables. *P≤0.0135, #P=0.0234 (vs AZT). (B) H2O2 production in adipocytes.
*P=0.0052, #P=0.0077 (vs AZT). (C) Mitochondrial variables. *P≤0.0469, #P=0.0452 (vs AZT). (D) Adipogenic variables after 0.01 μM ddC for 10 days and
posterior differentiation. (E) Mitochondrial variables after 0.01 μM ddC for 10 days and posterior differentiation. *P≤0.0480.
1448
RESEARCH ARTICLE Disease Models & Mechanisms (2015) 8, 1441-1455 doi:10.1242/dmm.021774
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
(NAC) or a superoxide-generating agent (Menadione), which
decreased and increased H2O2, respectively. OLI at 4 nM was
previously shown to increase H2O2 in mouse preadipocytes
(Carriere et al., 2003). It remains to be seen whether the
contrasting results were caused by differences in the OLI
concentration used or reflect true differences between the cells
from the two species.
DISCUSSION
Adipogenic differentiation increases OXPHOS biogenesis
In the hASCs used here, oxygen consumption, MIMP, CIV specific
activity and CIV quantity per cell increased with differentiation.
Thus, our results imply that adipogenic differentiation is
accompanied by OXPHOS biogenesis. Oxygen consumption is
also higher in differentiated than in immature primary subcutaneous
preadipocytes of young adults (von Heimburg et al., 2005). Higher
endogenous and uncoupled oxygen consumption is also observed
after adipogenic differentiation in hMSCs and in Simpson–Golabi–
Behmel syndrome subcutaneous preadipocytes (Keuper et al., 2014;
Zhang et al., 2013). Mitochondrial biogenesis is increased through
adipogenic differentiation of hMSCs (Tormos et al., 2011; Zhang
et al., 2013). Mitochondria of adipocytes are preferentially
distributed around the lipid droplets. Analagous to our findings
with hASCs, CS and SOD2 mRNA levels increase during
Fig. 6. Response of adipogenic and mitochondrial parameters to ribosomal antibiotics. Pink and light green bars indicate treatment with 2.5 μM CAM and
30 μM LIN, respectively. Dotted lines represent levels in untreated adipocytes. (A) Adipogenic variables. *P≤0.0008. (B) H2O2 production in adipocytes. Dark
green bar indicates treatment with 60 μM LIN. *P=0.0396. (C) Mitochondrial variables. *P≤0.0273, #P≤0.0040 (vs CAM). (D) Mitochondrial protein synthesis.
Representative gel showing the electrophoretic patterns of MTP (right) and loading controls (left). M, molecular weight marker;−, untreated hASCs; +, 30 μMLIN-
treated hASCs. Insert: quantification of MTPs in LIN-treated hASCs. Dotted line represents the level of MTPs in untreated hASCs. *P=0.0071. (E) Response of
secreted leptin and mitochondrial variables to 30 μM (light green bars) and 60 μM (dark green bars) LIN in differentiated hASCs-1 (solid bars) and hASCs-2
(striped bars). Dotted line represents levels in untreated adipocyte-differentiated hASCs-1 or hASCs-2. *P≤0.0366, #P≤0.0329 (vs 30 μM LIN), &P≤0.0225 (vs
differentiated hASCs-1).
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adipogenic differentiation of hMSCs derived from bone marrow
aspirates (Hofmann et al., 2012; Zhang et al., 2013). Moreover, the
mRNA levels of cytochrome oxidase subunit 3 (p.MT-CO3) and
the quantity of OXPHOS supercomplexes are strikingly increased in
adipocyte mitochondria compared with undifferentiated cells
(Hofmann et al., 2012). Similar results have also been obtained
with cells from other species (Luo et al., 2008; Ryu et al., 2013; Shi
et al., 2008; Wilson-Fritch et al., 2003). Therefore, considering that
diverse differentiation protocols have been used in these reports, the
collective results confirm that mitochondrial biogenesis is a
common phenomenon during adipocyte differentiation.
Inhibitors of mtDNA replication affect adipogenic
differentiation
Antiretroviral therapy has been effective in lowering acquired
immunodeficiency syndrome incidence among patients infected
with HIV. However, NRTIs used as a component of these therapies
can cause serious mitochondrial toxicity because they also inhibit
mtDNA polymerase-γ. It was previously shown that NRTIs might
affect OXPHOS function and adipocyte differentiation and that
mtDNA genetic background (haplotype) influences the propensity
for lipoatrophy in patients receiving NRTIs (Hendrickson et al.,
2009). In the range of concentrations used in this study, AZT and
ddC have been shown to decrease Oil Red staining both in mouse
and human preadipocytes (Caron et al., 2004; Stankov et al., 2010,
2013, 2008; Walker et al., 2006). AZT at 1 μM also decreased
mtDNA and p.MT-CO2 levels in mouse preadipocytes (Walker
et al., 2006) but, even at 6 μM, did not have any effect on mtDNA
levels or on specific activities of CIV or CS in primary human
subcutaneous preadipocytes (Stankov et al., 2010). ddC at 0.2 μM
decreased mtDNA and p.MT-CO2 abundance in mouse
preadipocytes (Walker et al., 2006). Even though ddC at 0.1 μM
Fig. 7. Response of adipogenic and
mitochondrial parameters to TBTC.White,
light and dark gray bars indicate 16 nM OLI-,
20 nM TBTC- and 100 nM TBTC-treated
hASCs, respectively. Dotted lines
represent levels in untreated hASCs.
(A-D) Representative microscopy images of
untreated hASCs (A), hASCs treated with
16 nM OLI (B), hASCs treated with 20 nM
TBTC (C) and hASCs treated with 100 nM
TBTC (D). (E) Adipogenic variables.
*P≤0.0256, #P=0.0221 (vs 20 nM TBTC).
(F) IDH levels. *P≤0.0173, #P=0.0030 (vs
20 nM TBTC). (G) Determination of oxygen
consumption just after drug addition.
*P≤0.0403. (H) Oxygen consumption plot.
Blue and red lines represent oxygen
concentration and consumption,
respectively. (I) Determination of H2O2 levels
after drug addition. White, gray, black and
dotted bars represent 16 nM OLI-, 100 nM
TBTC-, 100 nM TBTC+5 mM NAC- and
10 μM Menadione-treated hASCs,
respectively. *P≤0.0021, #P<0.0001 (vs
100 nM TBTC).
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decreased mtDNA levels in primary human subcutaneous
preadipocytes, it did not alter CIV or CS specific activities
(Stankov et al., 2010). In hASCs, ddC at 0.1 μM decreased Nile
Red staining, amount of triglycerides, secreted leptin, ROS
production and mtDNA levels, but did not affect the CIV/CS
ratio. However, AZT at 6 μM decreased mtDNA levels and
increased the CIV/CS ratio, but did not have an effect on the
other parameters.
It is remarkable that NRTIs seem to affect mtDNA and lipid
levels in diverse cell types from different species and using distinct
concentrations and differentiation protocols. mtDNA depletion is a
result of inhibition of mtDNA polymerase-γ by NRTIs. Curiously,
NRTI-mediated mtDNA depletion of mouse preadipocytes is
accompanied by a decrease in p.MT-CO2 levels and MIMP
(Walker et al., 2006), whereas mtDNA depletion in hASCs (here)
or in primary human subcutaneous adipocytes is not followed by
CIV deficiency (Stankov et al., 2010). Preserved CIV activity in
adipose tissue of HIV-infected patients with lipoatrophy, despite
mtDNA depletion, has been previously documented (Kim et al.,
2005, 2008). Thymidine kinase 2 (TK2) deficiency in humans
causes mtDNA depletion syndrome (Sun and Wang, 2014).
mtDNA-depleted TK2-deficient mice show reduced fat
accumulation and severe reduction in leptin mRNA and
circulating levels of leptin (Villarroya et al., 2011). However, CIV
activity is not lowered in WAT from TK2-deficient mice, despite a
significant reduction in mtDNA-encoded transcripts and moderate
mtDNA depletion (Villarroya et al., 2011). It remains possible that
other OXPHOS complexes are preferably affected in this model.
That the mtDNA depletion directly decreases lipid accumulation is
supported by the fact that treatment of mouse 3T3-L1 cells with
ethidium bromide (which depletes mtDNA) decreases the intensity
of Oil Red O staining (Ryu et al., 2013).
When 0.1 μM ddC was supplied for 10 days before the
differentiation protocol, the parameters of adipogenic
differentiation were no different to those of untreated cells.
However, CIV specific activity and quantity, normalized by CS
specific activity, were significantly increased. Almost the same
relationship between differentiation and mitochondrial variables
was observed when AZT 6 μM was provided to hASCs during the
differentiation protocol. Possibly, OXPHOS compensation is able
to improve differentiation factors.
Inhibitors of mitochondrial translation affect adipogenic
differentiation
It is known that some antibiotics that target bacterial ribosome also
inhibit mitochondrial protein synthesis (Pacheu-Grau et al., 2010),
but their potential effect on adipocyte differentiation has not been
previously studied. We have shown here that ribosomal antibiotics
CAM and LIN impair differentiation of hASCs, as evidenced by
decreased intracellular triglycerides and secreted leptin. LIN also
significantly decreased CIV/CS ratios and inhibited mitochondrial
protein synthesis. However, Nile Red staining of hASCs was not
decreased with CAM or LIN, which is similar to previous results on
lipophilic staining of mouse preadipocytes treated with CAM
(Vankoningsloo et al., 2006). Cellular fat stores primarily take the
form of triglycerides, and there is some data indicating that Nile Red
staining does not always correspond to quantitative triglyceride
assays. In Caenorhabditis elegans, for example, the major fat stores
are not normally stained by Nile Red, but the stain is found
exclusively in lysosome-related organelles (O’Rourke et al., 2009;
Zhang et al., 2010). It remains to be seen whether the observed
discrepancy between triglycerides and lipophilic staining could be,
at least partially, a result of the nonspecificity of stained
compartments in hASCs.
In our hands, LIN diminished leptin secretion but did not affect
two other adipokines (adiponectin and FABP4). A different
regulation for these adipokines in response to ETC inhibition has
been previously reported. Thus, leptin and adiponectin expression
were decreased and increased, respectively, in mouse preadipocytes
treated with the respiratory complex I (CI) inhibitor capsaicin that,
similarly to LIN, also decreased triglyceride levels (Hsu and Yen,
2007). Moreover, adiponectin and leptin release was increased and
decreased, respectively, in human adipocytes differentiated at 10%
oxygen compared with 21% (Famulla et al., 2012). The explanation
could be that leptin, adiponectin and FABP4 secretion involve
distinct intracellular compartments: endosomal compartments are
required for adiponectin but not for leptin secretion (Xie et al.,
2008), and FABP4 is actively released via a non-classical, calcium-
dependent mechanism (Schlottmann et al., 2014). However,
currently there is no information on how these pathways could be
selectively modulated by mitochondrial activity.
Very interestingly, for 60 μM LIN, the CIV/CS ratio was
significantly lower in hASCs with mtDNA from haplogroup
H10e2 (hASCs-2) than in haplogroup T2c1d1a (hASCs-1), and
the same was observed with secreted leptin. We have previously
found that the amount of mitochondrial translation products, the
p.MT-CO1/succinate dehydrogenase complex subunit A (SDHA)
ratio and the CIV/CS ratio were significantly lower after treatment
with LIN in osteosarcoma 143B cybrids harboring the mtDNA
m.3010A allele (Pacheu-Grau et al., 2013). This nucleotide position
is located in the 16S ribosomal RNA, where LIN binds. The two
hASCs types used here have the m.3010G allele, but approximately
one quarter of western European individuals (mtDNA haplogroups
H1 and J1) harbor the A variant. These individuals would be even
more sensitive to the inhibitory effects of LIN on adipogenic
differentiation. Here, the differences in CIV and secreted leptin
between cells treated with different concentrations of LIN, and
between hASCs-1 and hASCs-2, emphasize the importance of
OXPHOS function on adipocyte differentiation that can be
significantly modified by mtDNA haplotype.
Inhibitors of OXPHOS complex activities affect adipogenic
differentiation
It was long thought that the effect of TBTon adipocyte differentiation
was solely through genomic pathways via PPARγ and RXRα
(Kanayama et al., 2005). However, the role of TBTas PPARγ agonist
in hASCs is questionable. It has been shown that hASCs do not
express PPARγ before adipogenic differentiation. The same seems to
be true in mouse mesenchymal stem cells (mMSCs) C3H10T1/2.
Thus, during undifferentiated growth, PPARγ2 is rarely expressed. In
C3H10T1/2, exposure to 100 nM TBT during undifferentiated
growth increased expression of the adipogenic marker genes
FABP4 and PPARγ2, and subsequently increased triglyceride
levels. However, treatment with the PPARγ2 agonist rosiglitazone
had no significant effect on subsequent adipogenic differentiation.
Moreover, silencing of PPARγ had no additional impact on the
regulation of cell fate markers, over that already observed with TBT.
These results suggest that the TBT-induced adipogenic mechanisms
act independently of PPARγ2 during undifferentiated growth
(Biemann et al., 2014) and, in part, during the induction of
differentiation in mMSCs (BMS2) (Yanik et al., 2011).
It has been shown that the proton channel of the F1F0 ATP
synthase is a target of TBT, possibly through formation of Sn-O
bonds at crucial, conserved amino acid residues (Grun, 2014). This
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leads to inhibition of proton flow and reduction in intracellular ATP
levels (Matsuno-Yagi and Hatefi, 1993; von Ballmoos et al., 2004).
Accordingly, our results suggest that TBTC induces adipogenesis
by an OXPHOS-mediated mechanism.Moreover, 6-day exposure to
25 nM TBT provoked a significant decrease in ATP levels and loss
of lytic function in human natural killer cells (Dudimah et al., 2007).
Inhibition of OXPHOS CV could also explain TBT-dependent
isocitrate accumulation (Yamada et al., 2014), as NAD+ required for
its oxidation would not be regenerated by an inhibited ETC. It was
reported that OXPHOS CV inhibitor OLI at 8 nM induces
triglyceride accumulation in 3T3-L1 cells (Vankoningsloo et al.,
2005), which is similar to our results.
Published data on the potential role of inhibition of other
OXPHOS complexes are somewhat contradictory. Rotenone, a CI
inhibitor, decreased Oil Red O staining and adiponectin mRNA
levels of adipocyte-differentiated hMSCs (Zhang et al., 2013) but
induced lipid accumulation in hASCs (Kim et al., 2014). Antimycin
A, a complex III (CIII) inhibitor, decreased adipogenic
differentiation of 3T3-F442A mouse preadipocytes (Carriere
et al., 2004) but again induced adipogenesis in hASCs (Kim
et al., 2014). Additionally, it has been shown that antimycin A, as
well as stigmatellin and myxothiazol (other CIII inhibitors), can
induce triglycerides in 3T3-L1 cells (Vankoningsloo et al., 2006,
2005). Thus, more detailed work on different classes of ETC
inhibitors are required to evaluate their adipogenic versus
antiadipogenic effects on various types of cells capable of
adipogenic differentiation.
Conclusions
Here, we have shown that the mitochondrial OXPHOS system is
important for regulation of adipogenesis in hASCs and that its
inhibition at the level of mtDNA replication (NRTIs), organelle
protein synthesis (antibiotics) or function (TBTC) can either inhibit
or promote adipogenesis in vitro. Because important OXPHOS
components are mtDNA-encoded and OXPHOS capacity is
affected by mtDNA haplogroup (Gomez-Duran et al., 2010,
2012), genetic variability in mtDNA could affect adipocyte
differentiation and related phenotypes such as obesity (Knoll
et al., 2014; Nardelli et al., 2013; Yang et al., 2011).
In the fight against infectious diseases, as well as in agricultural
pest control, therapies are based on the selective toxicity of the
used drug or xenobiotic against the non-desired agent. In this
light, the human OXPHOS system can be seen as the unintended
off-target of some drug treatments and responsible, at least in part,
for adverse events associated with a large array of compounds
(Wallace, 2008), including those related to adipogenic
differentiation. As previously commented, mtDNA haplogroups
modify the lipoatrophy propensity of patients being treated with
NRTIs (De Luca et al., 2012; Hendrickson et al., 2009; Hulgan
et al., 2011). mtDNA haplogroups can also define cell susceptibility
to inhibitors of mitochondrial protein synthesis (Pacheu-Grau et al.,
2013). These observations suggest that the mtDNA genotype is a
risk factor for lipoatrophy in patients treated with OXPHOS
xenobiotics.
If the potential side effects (such as altered adipocyte
differentiation) of a particular pharmacological intervention are
known, they can be monitored and possibly prevented. However,
human exposure to a myriad of other OXPHOS xenobiotics that
affect adipocyte differentiation is unknown and uncontrolled. Thus,
as the obesogen hypothesis postulates (Grun, 2014), environmental
chemical pollutants such as TBT that promote adipose-dependent
weight gain might lead to obesity and metabolic syndrome.
MATERIALS AND METHODS
Chemicals
All reagents used were of research or cell culture quality. AZT and ddC,
which affect mitochondrial function and adipogenic differentiation; CAM,
LIN and OLI, which affect mitochondrial function; and TBTC, which
affects adipogenic differentiation, were purchased from Sigma-Aldrich
(St Louis, MO, USA).
Cells, growth and differentiation conditions
StemPro® Human Adipose-Derived Stem Cells (#R7788-115,
Invitrogen™, Life Technologies™) derive from human adipose tissue
collected during liposuction procedures and were cryopreserved at passage 1
from primary cultures. Each lot of hASCs originates from a single donor of
human lipoaspirate tissue, and the two lots used here are named hASCs-1
and hASCs-2. hASCs were generally grown in MesenPRO RS™ medium
(Invitrogen™, Life Technologies™), containing 5 mM glucose and 2%
fetal bovine serum complemented with MesenPRO RS™ growth
supplement and 2 mM L-glutamine prior to use. To avoid undesired
phenotypic effects, cells were grown in the absence of antibiotics (Llobet
et al., 2015). The doubling times were determined using the Z2 Beckman
Coulter. Initially, 2×104 cells per well were seeded in a six-well plate. Three
replicate growth curves were performed and cells counts were performed in
duplicate at each time point (0, 24, 48, 72 and 96 h). For the hypoxia
treatment, cultures were transferred to an H35 Hypoxystation (Don Whitley
Scientific), where the incubation proceeded in atmosphere containing 5%
CO2 and 3% O2 balanced with nitrogen.
To induce adipogenic differentiation, confluent hASCs were incubated for
21 days with StemPro® Adipogenesis Differentiation Kit (Invitrogen™).
Because this differentiation medium contains 25 mM glucose, the glucose
concentration of the control culture medium (MesenPRO RS™) for
undifferentiated cells was also raised to 25 mM in experiments where
undifferentiated and differentiated cells were compared.
For osteogenic differentiation, hASCs were grown to 50% of confluence
and then incubated for 14 days with StemPro® Osteogenesis Differentiation
Media (Invitrogen™). For assessment of calcium deposition, cells were
washed with phosphate-buffered saline (PBS), fixed for 30 min in 4%
paraformaldehyde at room temperature and washed with distilled water.
Samples were incubated for 5 min at room temperature in 30 mM Alizarin
Red in distilled water, washed and visualized using an inverted microscope.
For chondrogenic differentiation, 80% confluent hASCs were harvested
and micromass cultures were generated by seeding the center of 96-well
plate wells with 5 μl droplets from a cell suspension containing 1.6×107
cells/ml. After 2 h, warmed StemPro® Chondrogenesis Differentiation
Medium (Invitrogen™) was added and the micromass cultures were
incubated for 14 days. The differentiated cell aggregates were fixed with 4%
paraformaldehyde for 30 min at room temperature and stained with 1%
Toluidine Blue in 70% ethanol, which detects glycoproteins in the
extracellular matrix. An inverted microscope was used for imaging.
Metabolic markers
Glucose concentration was measured by an enzymatic colorimetric GOD-
POD method with the Glucose Liquid reagents (Química Clínica Aplicada
S.A., Tarragona, Spain) following a previously described protocol (Trinder,
1969). Briefly, the cells under study were seeded, supernatant samples were
collected three times per day (6 h intervals) and absorbance was measured at
510 nm using the NovoStar MBG Labtech microplate instrument.
Lipid accumulation was assessed by Oil Red O staining. Briefly, cells
werewashed with PBS, fixed with 4% paraformaldehyde for 30 min at room
temperature and incubated for 30 min at 37°C in freshly diluted and filtered
16 µM Oil Red O solution in isopropanol. Alternatively, intracellular lipids
were stained with the hydrophilic stain Nile Red that, when partitioned
in a hydrophobic environment, becomes fluorescent. For quantitative
determination of Nile Red fluorescence, the NovoStar MBG Labtech
microplate instrument was used (Ex: 485 nm/Em: 572 nm). Images were
acquired either with a DMIL inverted microscope (Leica) or FLoid Cell
Imaging Station (Life Technologies™).
Adipogenesis Detection Kit (Abcam) was used to quantify triglyceride
accumulation in cells according to the manufacturer’s instructions.
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In this assay, triglycerides are solubilized and hydrolyzed to glycerol, which
is subsequently oxidized to convert the probe to generate color
(λmax=570 nm). A NovoStar MBG Labtech microplate instrument was
used for measurements. For quantitative determination of adiponectin,
FABP4 and leptin in cell culture supernatants, Human Adiponectin ELISA
kit (Millipore), FABP4 Human ELISA kit (Symansis) and Leptin Human
ELISA Kit (Abcam) were used. Media were centrifuged for 5 min at
1400 rpm (Beckman Coulter Allegra X-22, SX4250 rotor) and supernatants
diluted for use in the quantification reaction. Concentrations were
determined according to the manufacturer’s instructions.
For immunocytochemistry, the cultured cells were fixed with 4%
paraformaldehyde for 15 min at room temperature and permeabilized with
0.1% Triton X-100 for 10 min. After blocking with 0.1% bovine serum
albumin, the washed cells were incubated for 1 h at room temperature with
a primary antibody against FABP4 (Invitrogen). Subsequently, the cells
were incubated with fluorescence-labeled secondary Alexa Fluor® 594
(Molecular Probes) at room temperature for 30 min, protected from light.
The cells were further incubated with 1 µM 4′,6-diamidino-2-phenylindole
(DAPI) for nuclear staining. Between incubations, samples were washed
with PBS containing 0.05% Tween.
Electron microscopy
For ultrastructural analysis, hASCs were seeded in Permanox®
chamberslides (NUNC), fixed with 2.5% glutaraldehyde for 2 h at 4°C
and maintained in phosphate buffer supplemented with 0.05% sodium
azide. Post-fixation was carried out using 1% OsO4 for 2 h. The cells were
dehydrated in a graded series of ethanol up to absolute. The specimens were
then passed through different mixtures of ethanol and araldite (3:1, 1:1, 1:3)
and embedded in pure araldite. After 3 days polymerization at 70°C,
ultrathin sections were cut and stained following a previously published
protocol (Reynolds, 1963). The sections were examined with a JEOL 1010
transmission electron microscope using a Gatan Bioscan camera and the
Digital Micrograph software.
Analysis of mitochondrial function
To measure mitochondrial content, mitochondria were labeled using the
mitochondria-specific dye MitoTracker® Red (Molecular Probes™),
according to the manufacturer’s protocol. The final dye concentration was
100 nM and the incubation time was 30 min at 37°C prior to visualization.
Fluorescent microscopy was performed on live cells using a FLoid
Cell Imaging Station (Life Technologies™). MIMP was measured in
triplicate in three independent experiments using the Mito-ID Membrane
Potential Cytotoxicity kit (ENZO®) following the manufacturer’s
instructions. MIMS, based on the quantity of cardiolipin, was measured
three times in three independent experiments using nonylacridine-orange
(Sigma) (Petit et al., 1992). H2O2 production was measured in triplicate
using 2′,7′-dichlorofluorescin diacetate (Sigma) as described previously
(Carter et al., 1994), with minor modifications. A Beckman Coulter
Cytomics FC500 cytometer was used for measurement of intracellular
fluorescence, and Weasel software was used for flow cytometry data
analysis.
Oxygen consumption was analyzed using the high-resolution oxygraph
OROBOROS® (Oroboros Instument, Innsbruck, Austria). Exponentially
growing cells were collected by trypsinization, then washed, counted and
resuspended at 1×106 cells/ml in DMEM. Endogenous, leaking (with OLI
added at 16 nM) and uncoupled (with FCCP added at 0.8 µM) respiration
analyses were performed. To correct for oxygen consumption not due to the
ETC, inhibition of mitochondrial respiration by KCN was performed. Each
condition was analyzed three times. Respiration was measured at 37°C, with
chamber volumes set at 2 ml. The software DatLab (Oroboros Instrument,
Innsbruck, Austria) was used for data acquisition at 1 s time intervals, as
well as for data analysis (Gnaiger et al., 1995).
The enzymatic activities of OXPHOS CII and CS and their protein levels
were assayed following previously described protocols (Faloona and Srere,
1969; King, 1966; Tzagoloff et al., 1967). CIV activity and levels were
determined using the Complex IV Human Specific Activity Microplate
Assay Kit (Mitosciences, Abcam®) according to the manufacturer’s
instructions. All enzyme determinations were performed in triplicate in at
least three independent experiments using a NovoStar MBG Labtech
microplate instrument. IDH activity was determined using the commercial
Isocitrate Dehydrogenase Colorimetric Assay Kit (Abcam®), according to
the manufacturer’s instructions. Briefly, 1×106 hASCs grown in DMEM
were lysed in 200 µl of provided assay buffer. The lysate was centrifuged at
13,000 g for 10 min and the cleared supernatant used for the assay. NAD+
was used as substrate for the NAD-IDH assay. A NovoStar MBG Labtech
microplate instrument was used for the measurements.
Mitochondrial protein synthesis was analyzed as described previously
(Chomyn, 1996), with minor modifications. Electrophoresis was performed
with a Protean II xi system (Bio-Rad). As a loading control, we dyed the gel
for 15 min with fixing solution (30% methanol, 10% acetic acid) plus
0.025% Coomassie Blue (Brilliant Blue R, Sigma). The gel was washed
several times with 50% methanol, 10% acetic acid solution and left
overnight in fixing solution. Finally, the gel was treated for 20 min with
Amplify solution (Amersham), dried and used for autoradiography. The
band intensities from appropriate exposures of the fluorograms from three
independent gels were quantified by densitometric analysis with the Gelpro
analyzer v4.0. Three bands, corresponding to the upper, middle and lower
parts of the gel, were selected for quantification.
Genetics characterization and gene expression analysis
For molecular cytogenetic analysis, cells were exposed to colchicine
(0.5 µg/ml) for 4 h at 37°C and harvested routinely. Metaphases were
prepared following a conventional cytogenetic protocol for cells fixed in
methanol:acetic acid (3:1). Approximately 20 metaphase cells were
captured and analyzed for each cell line. The genetic fingerprints of the
cells were performed with the AmpFLSTR® Identifiler® PCRAmplification
Kit (Life Technologies). The mtDNA sequences were obtained using the
BigDye Terminator v3.1 Cycle Sequencing Kit (Applera Rockville, MD,
USA) and an ABI Prism 3730xl DNA analyzer (Applied Biosystems, Foster
City, CA, USA). To locate mutations, the revised Cambridge Reference
Sequence (rCRS) was used (GenBank NC_012920) (Andrews et al., 1999).
The mtDNA content was measured by the real-time quantitative reverse
transcription-polymerase chain reaction (RT-qPCR) method using an
Applied Biosystems StepOne™ Real-Time PCR System Thermal Cycling
Block, as described elsewhere (Marcuello et al., 2005). The mtDNA levels
were determined in triplicate in three independent experiments.
To assess mRNA levels, total RNA was isolated from exponentially
growing cells using a NucleoSpin® RNA II kit (Macherey-Nagel) according
to the manufacturer’s protocol. Total RNA (1 µg) was reversed-transcribed
with the Transcriptor First Strand cDNA Synthesis Kit (Roche), using the
manufacturer’s conditions. The levels of CD90/THY1 and CD105/ENG,
FABP4, PGC1α, PPARγ, VEGF, PFKL and SOD2mRNAs and cytochrome
oxidase subunit 1 (p.MT-CO1), 12S ribosomal RNA and NADH-
ubiquinone oxidoreductase chain 6 (p.MT-ND6) mitochondrial RNA
were determined in triplicate in three independent experiments by RT-qPCR
using the One-Step Real-Time system (Applied Biosytems). The expression
levels were normalized using the 18S ribosomal RNA. The ΔCt method was
used to calculate fold expression. StepOne software version 2.0 (Applied
Biosystems) was used for data analysis.
Statistics
The statistical package StatView 6.0 was used to perform all the statistics.
Data for mean, standard deviation and number of independent experiments
or replicates are presented. The Kolmogorov–Smirnov test was used to
check the normal distribution. The unpaired two-tailed t-test was used to
compare parameters. P values lower than 0.05 were considered statistically
significant.
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